RESUMEN
OBJECTIVES: To conduct a systematic review and meta-analysis to assess whether individuals with nonsyndromic orofacial clefts (OCs) display a higher frequency of dental anomalies (DAs) when compared with individuals without OCs. METHODS: A literature search of indexed databases (PubMed, Cochrane, Web of Science, Embase, Scopus, and LILACS) was conducted without language restriction up to and including February 1, 2020. Cross-referencing was used to further identify articles. Several cleft teams across the United States and Europe were contacted to obtain unpublished data. The eligibility criteria were observational studies with original data that statistically compared individuals with OC without syndromes and those without OC on any type of DA in primary and/or permanent dentition. Random effects meta-analysis through the Mantel-Haenszel estimator was used to evaluate the association between OC and DA based on odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS: The literature search generated 933 records, and 75 full-text articles were reviewed. Twenty-six studies encompassing 15,213 individuals met the inclusion criteria. The meta-analysis revealed statistically significant associations between OC and agenesis (OR, 14.2; 95% CI, 9.4 to 21.3), supernumerary teeth (OR, 5.7; 95% CI, 3.3 to 9.7), developmental enamel defects (OR, 5.6; 95% CI, 3.5 to 9.0), microdontia (OR, 14.8; 95% CI, 4.0 to 54.6), peg-shaped anterior teeth (OR, 12.2; 95% CI, 3.6 to 41.2), taurodontism (OR, 1.7; 95% CI, 1.0 to 2.7), tooth malposition and/or transposition (OR, 5.6; 95% CI, 2.8 to 11.5), tooth rotation (OR, 3.2; 95% CI, 1.3 to 8.2), and tooth impaction (OR, 3.6; 95% CI, 1.1 to 12.2). The OR estimates of the reviewed studies exhibited significant heterogeneity (P < 0.0001). No association was observed between OC and fusion and/or gemination. CONCLUSION: Within the limitations of this study, the available evidence suggests that individuals with OCs are more likely to present with a range of DAs than their unaffected peers. KNOWLEDGE TRANSFER STATEMENT: The findings of the current review suggest that individuals with orofacial clefts (OCs) are more likely to present with a range of dental anomalies than their unaffected peers. Understanding the association between OCs and dental anomalies is essential in guiding clinicians during treatment-planning procedures and is important in raising our awareness of the possible need for future dental treatment for patients with OCs.
Asunto(s)
Labio Leporino , Fisura del Paladar , Anomalías Dentarias , Diente Supernumerario , Labio Leporino/epidemiología , Fisura del Paladar/epidemiología , Dentición Permanente , Humanos , Anomalías Dentarias/epidemiologíaRESUMEN
Recently, a transthyretin variant, TTR Met 119, in which methionine substitutes for threonine 119, a component of the protein's iodothyronine binding site, was identified in individuals with transient euthyroid hyperthyroxinemia. Healthy carriers of Met 119 have normal serum thyroid hormone concentrations, but two studies of Met 119 carriers have differed as to whether T4 binding to TTR is increased. An additional kindred has been identified by hybrid isoelectric focusing in an ongoing screening program for TTR variants in the Portuguese population with TTR Met 30 associated familial amyloidotic polyneuropathy. Cyanogen bromide peptide mapping and DNA restriction length polymorphism analyses showed that the propositus was a compound heterozygote for two TTR variants: Asn 90 and Met 119. Family analysis revealed that he inherited the TTR Met 119 variant from the mother and the TTR Asn 90 variant from the father. Neither the compound heterozygote nor his parents had symptoms of familial amyloidotic polyneuropathy. Serum dialysis with stepwise saturation of iodothyronine binding sites confirmed that TTR binding of T4 is increased in TTR Met 119. The increased binding is due to a higher TTR concentration rather than an increased association constant for T4. Because of the small proportion of serum T4 bound by TTR, increased T4 binding by TTR did not affect the ratio of free to bound T4 or T4 concentrations. In contrast, plasma retinol binding protein, almost all of which is bound by TTR, was elevated. The Asn 90 mutation does not affect either the concentration or the hormone binding characteristics of the protein. Possible long-term effects of these mutations and the combined heterozygotic state remain to be determined.
Asunto(s)
Metionina/química , Prealbúmina/química , Tiroxina/metabolismo , Amiloidosis/genética , Asparagina , Sitios de Unión/genética , ADN/análisis , Femenino , Genotipo , Heterocigoto , Humanos , Hipertiroxinemia/metabolismo , Focalización Isoeléctrica , Masculino , Enfermedades del Sistema Nervioso/genética , Linaje , Mutación Puntual , Polimorfismo de Longitud del Fragmento de Restricción , Portugal , Prealbúmina/genética , Albúmina Sérica/análisis , Tirotropina/sangre , Triyodotironina/sangreRESUMEN
PURPOSE: In familial amyloid cardiomyopathy of Danish origin, the amyloid microfibrils contain a mutant transthyretin (TTR) with a methionine-for-leucine substitution at the molecular position 111. We studied the possible occurrence of this variant TTR-Met111 in serum from afflicted as well as nonafflicted family members and their offspring, in order to define its possible role as predictor of the disease and to describe its mode of inheritance. PATIENTS AND METHODS: Stored, frozen serum samples obtained from 1959 through 1960 from 36 of 40 living members of the kindred were analyzed. The method employed to detect the abnormal TTR was based on the electrophoretic separation of fragments produced by cyanogen bromide cleavage at the two methionine sites. RESULTS: All sera from family members with amyloid cardiomyopathy contained the variant transthyretin TTR-Met111 as did sera from half of their offspring. In contrast, nonafflicted family members and their offspring were seronegative for TTR-Met111. Three cousins from the second generation died between 1980 and 1986 of amyloid cardiomyopathy. The presence of variant TTR-Met111 preceded their deaths by 20 to 26 years. CONCLUSIONS: The occurrence in serum of the mutant transthyretin TTR-Met111 is linked to the occurrence of amyloid cardiomyopathy in patients and their offspring, while unafflicted branches of the family are negative for the variant protein. That the occurrence in serum of TTR-Met111 precedes the onset of clinical amyloid cardiomyopathy by several decades makes the variant TTR a marker for the disease. The distribution of afflicted family members and seropositivity for the variant TTR shows an autosomal dominant mode of inheritance. CLINICAL SIGNIFICANCE: The results make possible early detection of potential patients and provide tools for genetic counseling. Cardiac transplantation may provide a new therapeutic option.
Asunto(s)
Amiloidosis/genética , Cardiomiopatías/genética , Mutación , Prealbúmina/genética , Adulto , Anciano , Anciano de 80 o más Años , Amiloidosis/sangre , Cardiomiopatías/sangre , Dinamarca , Electroforesis en Gel de Poliacrilamida , Femenino , Heterocigoto , Humanos , Masculino , Metionina/análisis , Metionina/genética , Persona de Mediana Edad , Linaje , Fragmentos de Péptidos/análisis , Prealbúmina/análisis , Dodecil Sulfato de SodioRESUMEN
This simple, reliable method for detecting the transthyretin-methionine30 [TTR(Met30)] mutation, found in patients with familial amyloidotic polyneuropathy (FAP), is based on production of an extra peptide fragment when the mutant TTR is treated with cyanogen bromide (CNBr). After electrophoresis of whole serum and excision of the TTR (prealbumin) band, the TTR-containing gel is incubated with CNBr, subjected to sodium dodecyl sulfate/polyacrylamide gel electrophoresis, and stained with silver to determine whether an abnormal CNBr fragment (residues 31-127) is present. Results can be obtained within two days. Several samples can be processed simultaneously, and no unusual equipment or reagents are required. The procedure is suitable for routine diagnosis of FAP and for epidemiological studies.
Asunto(s)
Amiloidosis/genética , Enfermedades del Sistema Nervioso Periférico/genética , Prealbúmina/genética , Electroforesis en Gel de Poliacrilamida , Humanos , Hidrólisis , Metionina , Mutación , Factores de RiesgoRESUMEN
Transthyretin methionine 30 (TTR Met 30), which is associated with familial amyloidotic polyneuropathy, originates in a single base substitution (A for G) in the second exon of the TTR gene. This autosomal dominant disease can be diagnosed by RFLP analysis of NsiI-digested DNA. The amplification of DNA by PCR improves the diagnosis method, making it suitable for prenatal diagnosis. Using PCR-amplified DNA, prenatal diagnosis of two at-risk fetuses was performed. Control Met 30 and normal DNA (either genomic or produced by site directed mutagenesis) were processed in parallel. The diagnosis was made by hybridization with allele-specific oligonucleotide probes, and later confirmed by screening of the mutant protein in the amniotic fluid and, when possible, in the sera from the newborns. TTR Met 30 was detected in the amniotic fluid of a positive fetus whose father was the carrier of the mutation. This indicates that the mutant protein is expressed very early in development.
Asunto(s)
Amiloide/biosíntesis , Amiloidosis/diagnóstico , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Prealbúmina/biosíntesis , Diagnóstico Prenatal , Líquido Amniótico/química , Femenino , Expresión Génica , Humanos , Hibridación de Ácido Nucleico , Sondas de Oligonucleótidos , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción , EmbarazoRESUMEN
The study of pathogenic and nonpathogenic transthyretin (TTR) variants is very important for the understanding of such TTR-related diseases as hereditary amyloidosis and also to establish a relationship between the structure and function of the molecule. Variants with clinical manifestations can be easily detected, but clinically silent variants can be detected only by population screening programs using specialized techniques. Hybrid isoelectric focusing (HIEF) in extremely flattened immobilized pH gradients (IPG) allows the detection of even neutral amino acid substitutions and has been used to analyze approximately 5,000 samples from the Portuguese population. Comparison with samples from carriers of three known TTR mutations (Met 30 associated with hereditary amyloidosis, Met 119, and Asn 90) was also made. In this study we detected: (1) 8 individuals carriers of TTR Met 30, (2) 35 carriers of TTR Met 119, (3) 12 carriers of TTR Asn 90, (4) 1 compound heterozygote for TTR Met 30/Met 119, and (5) 5 variants that presented a different pattern from the controls used. We also performed DNA sequencing analyses of two of the variants with the different band pattern in HIEF. The individuals were found to be carriers of TTR Ile 122 and TTR Thr 190, respectively. All the mutations detected, except for Asn 90, result from substitutions in CpG hot spots and thus can be rather frequent in the populations. Studies on the clinical evolution of the compound heterozygotes and on the physical-chemical properties of these hybrid TTRs will help to understand the pathogenicity associated with TTR.
Asunto(s)
Amiloidosis/genética , Variación Genética , Mutación , Prealbúmina/genética , Amiloidosis/epidemiología , Femenino , Pruebas Genéticas , Variación Genética/genética , Heterocigoto , Humanos , Hipertiroxinemia/genética , Focalización Isoeléctrica/métodos , Masculino , Mutación/genética , Linaje , Polimorfismo de Longitud del Fragmento de Restricción , Portugal/epidemiología , Prealbúmina/metabolismo , Proteínas de Unión al Retinol/metabolismo , Análisis de Secuencia de ADN , Hormonas Tiroideas/metabolismoRESUMEN
Recently, a new nonpathogenic transthyretin (TTR) variant-TTR R104H (TTR H104)-has been described in heterozygotic and compound heterozygotic individuals from a Japanese family with familial amyloidotic polyneuropathy (FAP). The compound heterozygotic individual, a carrier of TTR V30M (TTR M30) and TTR R104H (TTR M30/H104) presented a very mild form of FAP with slow progression of the disease. TTR and retinol binding protein (RBP) levels were found to be increased in serum from TTR H104 carriers. These characteristics are very similar to those found in compound heterozygotic carriers of TTR V30M-T119M (TTR M30/M119). To structurally compare these variants, we performed stability and thyroxine (T(4)) binding studies. TTR M30/H104 showed an increased resistance to dissociation into monomers similar to TTR M30/M119. This suggests that the His104 substitution has the same stabilizing effect on tetrameric TTR as the Met119 substitution. Concerning T(4) binding, TTR H104 presents a T(4) binding affinity lower than that of TTR M119, but still higher than normal TTR. However, TTR from the compound heterozygotic carrier of TTR M30/H104 presented a T(4) binding affinity lower than normal. The results indicate that the His 104 substitution induces structural alterations that increase the stability of the tetramer in compound heterozygotes for TTR M30 despite a lower affinity for T(4) binding. Thus, stability of TTR and binding affinity for T(4) may not be related. More detailed characterization of these variants is needed to clarify the structural alterations responsible for their increased stability.
Asunto(s)
Neuropatías Amiloides/genética , Variación Genética , Prealbúmina/genética , Sustitución de Aminoácidos , Neuropatías Amiloides/sangre , Neuropatías Amiloides/fisiopatología , Progresión de la Enfermedad , Heterocigoto , Humanos , Japón , Sustancias Macromoleculares , Mutagénesis Sitio-Dirigida , Prealbúmina/química , Prealbúmina/metabolismo , Tiroxina/metabolismoRESUMEN
Transthyretin (TTR) Ser 6 was originally described in a Scottish kindred without amyloidosis. This variant, arising from a G-->A transition in codon 6 that destroys an MspI site and creates a BsrI site, was present in none of 50 controls, and was therefore thought to be rare. This variant has subsequently been found in a normal human cDNA liver library and in two unrelated patients with familial amyloidosis and other TTR variants, raising the question whether it is actually a common polymorphism. To address this question, we performed PCR and restriction digestion of 574 DNA samples from people without evidence of amyloidosis or a known family history of amyloidosis. The TTR Ser 6 allele frequency was 33/558 (.060) in Caucasians (including 8/192 (.04) in North American Ashkenazic Jews, 16/218 (.07) in North American non-Jews, and 9/148 (.06) in Portuguese), 3(242 (.01) in African Americans, 0/140 in Africans, and 0/208 in Asians. These data are most suggestive of a single Caucasian founder and the known 25% admixture of "Caucasian" genes in the African-American population. Alternatively, as this variant arose from a transition at a CG dinucleotide "hot spot," it may have arisen on multiple occasions. These data indicate that TTR Ser 6 is a common non-amyloidogenic population polymorphism in Caucasians.
Asunto(s)
Frecuencia de los Genes , Polimorfismo Genético , Prealbúmina/genética , Amiloidosis/genética , Efecto Fundador , Glicina/genética , Humanos , Mutación Puntual , Serina/genética , Población Blanca/genéticaRESUMEN
Familial amyloidotic polyneuropathy (FAP) is an autosomal dominant hereditary type of lethal amyloidosis involving single (or double) amino acid substitutions in the amyloidogenic protein transthyretin (TTR). The most common type of FAP (Type I, or Portuguese) is characterized by a Val-->Met substitution at position 30. The Met30 variant of TTR has been produced by recombinant methods, crystallized in a form isomorphous with native TTR, subjected to X-ray analysis and compared structurally with the wild-type protein. The comparison shows that the effect of the substitution at position 30 is transmitted through the protein core to Cys10, the only thiol group in the TTR subunit, which becomes slightly more exposed. The variant TTR molecule is otherwise in a near-native state. Use of computer graphics has shown that it is possible to model a linear aggregate of TTR molecules, each linked to the next by a pair of disulphide bonds involving Cys10 residues. Formation of these disulphide bonds involves a small number of slightly short molecular contacts with native TTR molecules, most of which are relieved in the Met30 variant. We propose this model as a possible basis for a molecular description of the FAP amyloid fibrils.
Asunto(s)
Amiloidosis/genética , Metionina/genética , Enfermedades del Sistema Nervioso Periférico/genética , Prealbúmina/química , Aminoácidos/química , Simulación por Computador , Disulfuros/química , Modelos Moleculares , Prealbúmina/genética , Conformación Proteica , Difracción de Rayos XRESUMEN
The DNA from an individual with familial amyloidotic polyneuropathy was examined. It did not possess any of the mutations which have previously been associated with familial amyloidotic polyneuropathy. However, a novel 7.0 kb Sph I restriction fragment was discovered, and the mutation creating it was localized to exon 3 of the transthyretin gene. This mutation was inherited from a parent, and may result in an amino acid substitution for glu89, his90 or ala91. The patient's transthyretin has a lower pI than normal transthyretin.
Asunto(s)
Amiloidosis/genética , Mutación , Enfermedades del Sistema Nervioso/genética , Prealbúmina/genética , Secuencia de Aminoácidos , Amiloidosis/sangre , Secuencia de Bases , Codón/genética , ADN/sangre , ADN/genética , Exones , Femenino , Genes , Humanos , Masculino , Datos de Secuencia Molecular , Enfermedades del Sistema Nervioso/sangre , Linaje , Conformación Proteica , Mapeo RestrictivoRESUMEN
Transthyretin (TTR) is a plasma protein interacting with thyroxine T4 and retinol binding protein (RBP). Several variants of TTR with single amino acid substitutions have been identified as the major components of the amyloid fibrils of familial amyloidotic polyneuropathy (FAP), a fetal, autosomal dominant genetic disease. The elucidation of the molecular nature of the variants distinct from that of the wild-type TTR is crucial for understanding the amyloidogenesis in FAP, but our understanding is very poor mainly because of the unavailability of pure variant TTRs. In the present study, we used an Escherichia coli OmpA secretion vector (Ghrayeb et al., 1984) and achieved an effective production of the variant TTRs related to FAP including Met-30, Ile-33, Ala-60, Tyr-77, Met-111, and Ile-122 types. The variant TTRs produced in this system were efficiently secreted to the culture media. The chemical analysis showed that the secreted TTR (Met-30 type) has the same N-terminus as the native one. IEF analyses also indicated that the secreted product is properly processed as assessed by its pI. Furthermore, the secreted TTR was shown to have biological activities, namely, the thyroxin binding activity and the ability to associate with retinol binding protein, indicating that the secreted TTR polypeptide is properly folded. The present work also demonstrated that the processing/secretion of the recombinant TTR molecules in E. coli was strongly affected by single amino acid substitutions.
Asunto(s)
Amiloidosis/genética , Mutagénesis Sitio-Dirigida , Enfermedades del Sistema Nervioso Periférico/genética , Prealbúmina/metabolismo , Proteínas de Unión al Retinol/metabolismo , Tiroxina/metabolismo , Secuencia de Aminoácidos , Amiloidosis/sangre , Secuencia de Bases , Clonación Molecular , Escherichia coli/genética , Femenino , Variación Genética , Humanos , Masculino , Datos de Secuencia Molecular , Sondas de Oligonucleótidos , Linaje , Enfermedades del Sistema Nervioso Periférico/sangre , Prealbúmina/genética , Proteínas Recombinantes/metabolismo , Mapeo Restrictivo , Proteínas Plasmáticas de Unión al RetinolRESUMEN
A mutation in transthyretin (TTR Asn 90) has been identified in the Portuguese and German populations. This variant has a lower pI and was found by screening analyses in 2/4,000 German subjects and in 4/1,200 Portuguese by using either double one-dimensional (D1-D) electrophoresis with isoelectric focusing (IEF) or hybrid isoelectric focusing in immobilized pH gradient (HIEF) as the final separation step. The Portuguese population sample was from the area where TTR Met 30-associated familial amyloidotic polyneuropathy (FAP) prevails, and it was divided into (a) a group of 500 individuals belonging to FAP kindreds and (b) a group of 700 collected at random. HIEF showed two particular situations: (1) one case, from an FAP kindred, was simultaneously carrier of the Met 30 substitution and the acidic variant, and (2) one individual, from the randomly selected Portuguese sample, had only the acidic monomer. Comparative peptide mapping, by HPLC, of the acidic variant carriers and of normal TTR showed the presence of an abnormal tryptic peptide, not present in the normal TTR digests, with an asparagine-for-histidine substitution at position 90 explained by a single base change of adenine for cytosine in the histidine codon. This was confirmed at the DNA level by RFLP analyses of PCR-amplified material after digestion with SphI and BsmI. In all carriers of the Asn 90 substitution, no indicators were found for an association with traits characteristic for FAP.
Asunto(s)
Amiloidosis/genética , Mutación/genética , Enfermedades del Sistema Nervioso Periférico/genética , Prealbúmina/genética , Adulto , Femenino , Alemania , Heterocigoto , Humanos , Masculino , Linaje , PortugalRESUMEN
Recently, a new transthyretin (TTR) variant was described in the normal Portuguese and German populations. The same substitution was found associated with familial amyloidotic polyneuropathy (FAP) in an American family of Italian origin. Comparative isoelectric focusing studies showed a difference in the mobility pattern between the non-pathogenic and pathogenic variants. However, comparative DNA sequencing between them did not reveal any additional mutation. Comparative isoelectric focusing between the variants and TTR Asn 90 produced by recombinant techniques indicated that the non-pathogenic variant has the electrophoretic behaviour expected for the mutation. We suggest that an as yet unknown post-translational modification may have occurred in the FAP-associated Asn 90 variant, turning it into an amyloidogenic molecule.
Asunto(s)
Amiloidosis/genética , Enfermedades del Sistema Nervioso Periférico/genética , Prealbúmina/genética , Amiloidosis/metabolismo , Secuencia de Bases , Femenino , Humanos , Focalización Isoeléctrica , Masculino , Datos de Secuencia Molecular , Enfermedades del Sistema Nervioso Periférico/metabolismo , Polimorfismo de Longitud del Fragmento de Restricción , Prealbúmina/biosíntesis , Homología de Secuencia de Ácido NucleicoRESUMEN
We have analysed the structure, binding properties, stability and amyloidogenicity of particular transthyretin (TTR) mutations-TTR Met30 and TTR Pro55, both associated with familial amyloid polyneuropathy, and TTR Met119, a non-pathogenic TTR mutation with apparent protective effects on the amyloidogenicity of the Met30 mutation. Our results show that in contrast to the Met30 mutation, the Met119 mutation increases the stability of the tetramer towards dissociation into monomers and confers a higher affinity to thyroxine, which binds on the channel that runs through the tetramer. This variant also shows a greater resistance to amyloid formation in vitro, in contrast to the Pro55 variant, which is more susceptible to amyloid formation. Crystallographic studies of the structure of the Pro55 variant are underway and reveal major conformational changes. Interestingly, these changes affect the D strand of TTR, which when deleted or modified in vitro leads to accelerated rates of amyloid formation. The conformational changes observed in these "aggressive' mutations may resemble intermediate forms in the process of amyloidogenesis.